Updated:
National Institute of General Medical Sciences
NIGMS is a federal institute funding basic biomedical research, with $1.9B allocated in FY2023 primarily through R01 grants.
National Institute of General Medical Sciences
The National Institute of General Medical Sciences (NIGMS) was established as part of the National Institutes of Health, with the specific mandate to support basic research that increases understanding of biological processes and lays the foundation for advances in disease diagnosis, treatment, and prevention. NIGMS allocates funds primarily through investigator-initiated research grants, training grants, and career development awards across multiple disciplines: molecular biology, genetics, cell biology, pharmacology, physiology, and computational biology. Notable funded programs include the Institutional Development Award (IDeA) program, which enhances research capacity in states with historically low NIH funding, and the Biomedical Technology Research Resources program, which develops cutting-edge tools and services. Geographic footprint is nationwide, with funded institutions in every state, though the institute's headquarters and administrative center is Bethesda, Maryland. As a federal agency, NIGMS does not disclose AUM in the traditional asset-management sense, but its fiscal year 2023 congressional appropriation was approximately $1.9B for extramural and intramural research programs. The institute employs roughly 130 full-time staff across its Bethesda campus, per public records. No separate philanthropic foundations or for-profit spinouts are documented. In November 2023, NIGMS launched the "Synthetic Biology for Environmental Sustainability" program to support research on engineering biological systems for climate and environmental applications. NIGMS operates as a research-funding agency rather than a direct investor or grant-making foundation with endowed capital. Its structural differentiator is its exclusive focus on fundamental discovery science, without the disease-specific mandates of other NIH institutes, and its allocation of ~75% of its budget to investigator-driven R01 grants, which are awarded competitively based on scientific merit.
General information
Firm type
Foundation
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Bethesda
Corporate office
Bethesda, MD, United States
Sector focus
Frequently asked questions
How does NIGMS allocate its budget across research areas?
In fiscal year 2023, NIGMS allocated approximately $1.9B, with roughly 75% directed to investigator-initiated R01 research project grants, 10% to training and career development, and the remainder to research centers, infrastructure, and administrative support (per NIH public budget documents, 2023).
What types of institutions receive NIGMS funding?
Recipients include universities, medical schools, hospitals, research institutes, and small businesses across all 50 states. The IDeA program specifically targets institutions in 25 states and Puerto Rico that historically receive lower levels of NIH support (per NIGMS official website).
Does NIGMS fund research outside the United States?
NIGMS primarily funds domestic institutions, but it does support international collaborations through specific programs, such as the Fogarty International Center partnerships, which enable U.S.-led team research in low- and middle-income countries (per NIH policy documents).
What is the difference between NIGMS and other NIH institutes?
Unlike disease-focused institutes like the National Cancer Institute or National Heart, Lung, and Blood Institute, NIGMS funds fundamental basic science that crosses all diseases and biological systems. Its mission is to “lay the foundation for advances in disease diagnosis, treatment, and prevention.”
How does NIGMS evaluate grant applications?
Applications undergo peer review by a panel of scientific experts through the Center for Scientific Review. Reviewers assess scientific merit, innovation, investigator qualifications, and relevance to NIGMS's mission. Scores determine funding priority, with top-scoring applications funded until the budget is exhausted (per NIH grant review process).
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on endowments & foundations?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: